MetaCap

Veracyte Statistics

NASDAQ: VCYTHealth CareMedical SpecialitiesUSD

43.60+0.44 (+1.02%)

At close: Oct 8, 4:00 PM ET · Delayed 15 min

After hours: 43.00 -1.38%

Veracyte by the numbers

Veracyte has a market capitalization of $3.51 billion based on 80.39M shares outstanding. Its trailing P/E ratio is 31.1, below the 4-company peer median of 37.9, and its forward P/E is 22.4. The stock trades 1.6% below its 50-day average and 2.5% above its 200-day average.

Average daily trading volume is 1.35M shares, or about $58.8 million in dollar volume.

Summary generated from market data by MetaCap's automated system. Methodology

VCYT valuation vs. peer median

VCYT compared with the median of 8 peer companies
MetricVCYTPeer medianDifference
Market cap$3.51B$2.93B+19%
P/E (TTM)31.137.9-18%
Forward P/E22.419.9+12%
Avg. volume1.35M1.38M-2%

Peer median across 8 companies: CELC, CDNA, ACHC, BLLN, CLOV, CON, FTRE, ALHC.

Valuation

Price / sales (latest FY)
6.78

Price and trading

Previous close
43.16
Open
42.43
Day range
41.22 – 43.67
52-week range
29.46 – 60.91
52-week change
+24.70%
Beta
—
Volume
1.22M

Dividends and events

Annual dividend
None

Additional statistics

Market Cap
3.51B
Pe
31.14
Forward Pe
22.36
Eps
1.40
Dividend Yield
0.00%
Dividend Rate
0.00
Week52 High
60.91
Week52 Low
29.46
Avg Volume
1.35M
Shares Outstanding
80.39M
Ma50
44.30
Ma200
42.55
Earnings Date
Nov 3, 2026
Pct From52w High
-28.42%
Pct From52w Low
48.02%

Related